Switzerland (CH)

Mobility endpoints in marketing authorisation of drugs: What gets the European medicines agency moving? (2022) Jaeger SU, Wohlrab M, Schöne D, Tremmel R, Chambers M, Leocani L, Corriol-Rohou S, et al. Journal article, Review article European patch test results with audit allergens as candidates for inclusion in the European Baseline Series, 2019/20: Joint results of the ESSCAA and the EBSB working groups of the ESCD, and the GEIDACC (2022) Uter W, Wilkinson SM, Aerts O, Bauer A, Borrego L, Buhl T, Cooper SM, et al. Journal article Environmental effects of stratospheric ozone depletion, UV radiation, and interactions with climate change: UNEP Environmental Effects Assessment Panel, Update 2021 (2022) Barnes PW, Robson TM, Neale PJ, Williamson CE, Zepp RG, Madronich S, Wilson SR, et al. Journal article Cheap Talk and Cherry-Picking: What ClimateBert has to say on Corporate Climate Risk Disclosures (2022) Bingler JA, Kraus M, Leippold M, Webersinke N Journal article Roadmap on Spin-Wave Computing (2022) Chumak AV, Kabos P, Wu M, Abert C, Adelmann C, Adeyeye A, Akerman J, et al. Journal article Inclusion for all in VET? A comparative overview of policies and state of research about migration, integration and inclusion in Germany, Austria and Switzerland (2022) Kimmelmann N, Miesera S, Moser D, Pool Maag S Book chapter / Article in edited volumes Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database (2022) Gigante A, Hoffmann-Vold AM, Fegatelli DA, Gabrielli A, Leodori G, Coleiro B, De Santis M, et al. Journal article Economic applications of quantile regression 2.0 (2022) Fitzenberger B, Koenker R, Machado J, Melly B Journal article Spectral Characteristics of Soil Types in Northwestern Jordan Considering Iron Oxides Effects and Colors (2022) Sahwan W, Lucke B, Sprafke T, Vanselow K, Bäumler R Book chapter / Article in edited volumes Quality-Adjusted Survival with Ribociclib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Postmenopausal Women with HR±HER2− Advanced Breast Cancer in the MONALEESA-3 Trial (2022) Jerusalem G, Delea TE, Martin M, De Laurentiis M, Nusch A, Beck JT, Chan A, et al. Journal article